Dr. Viola Fox

Dr. Viola Fox

Snapshot Highlights

• Chief Physician of Haematology, Oncology, and Palliative Care at BKZ Solingen
• Leading specialist in tumor drug therapy in Germany and Europe
• Expert in chemotherapy, immunotherapy, targeted therapy, and molecular diagnostics
• Actively involved in molecular biology research for hematological diseases
• Distinguished member of the German Society of Oncology and Haemato-oncology (GDHO)

Professional Acumen and Leadership

Dr. Viola Fox presides as the Chief Physician for the Clinic for Haematology, Oncology, and Palliative Care at the esteemed interdisciplinary cancer centre, BKZ Solingen. Her leadership is instrumental in guiding advanced patient care within this certified facility.

Expertise in Oncological Therapies

Dr. Fox is recognized across Germany and Europe as a foremost expert in the drug therapy of malignant tumors. Her extensive knowledge base and dedication to continuous learning enable her to skillfully implement cutting-edge, modern, and evidence-based treatment methodologies, ensuring patients receive superior medical attention for optimal recovery.

Specialized Treatment Modalities

Her practice encompasses the comprehensive management of neoplastic diseases, with particular proficiency in:

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy
• Molecular Diagnostics

Commitment to Advancing Cancer Care

Dr. Fox is deeply engaged in molecular biology research focused on novel treatment strategies for hematological and oncological conditions. This commitment to research ensures that her patients benefit from the latest scientific advancements and personalized treatment plans.

Professional Affiliations and Recognition

Her professional standing is underscored by her membership in prestigious medical organizations, including the German Society of Oncology and Haemato-oncology (GDHO) and the American Association for Cancer Research. Dr. Fox also contributes her expertise as a reviewer for scientific journals and maintains close collaborative relationships with leading hematologists in the field.